Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2 1Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1CNS 1

Conditions

Early-stage Peripheral Non-small Cell Lung Cancer 1

Interventions

Carboplatin 551Pemetrexed 404Cisplatin 401Paclitaxel 273Docetaxel 255Gemcitabine 218pembrolizumab 191Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 181Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 107atezolizumab 92Gefitinib 74Radiosurgery 72anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 50Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Drug Delivery Systems × Thoracic × Clear all
NCT07167459 2025-09-11

Personalized SBRT in Early-Stage Peripheral NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Enrolling by invitation
251 enrolled
Thoracic

Early-stage Peripheral Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡